The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.
The National Institutes of Health (NIH) on July 30, 2020 made updates on use of corticosteroids in treatment of COVID-19 and on approaches to care of the crtically ill, including considerations for advance planning to its dynamic COVID-19 Treatment Guidelines. The guidelines are updated as soon as published data and other authoritative information become available. Following are highlights of the recent updates.
No Rx Required for COVID-19 Vaccination But ACIP Calls for Better Informed Consent Process
September 22nd 2025The ACIP on September 19 narrowly voted against requiring a prescription to get the shot but urged more detailed discussion of vaccine risks during shared decision making conversations.